EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering Useful Microbial Species for Pharmaceutical Applications

Amankeldi K Sadanov, Baiken B Baimakhanova iD, Saltanat E Orasymbet, Irina A Ratnikova, Zere Z Turlybaeva iD, Gul B Baimakhanova iD, Aigul A Amitova, Anel A Omirbekova iD, Gulzat S Aitkaliyeva, Bekzhan D Kossalbayev, Ayaz M Belkozhayev

Microorganisms · 05.03.2025 · 13 (3) · 599

DOI: 10.3390/microorganisms13030599 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 05.03.2025. Verfasst von Amankeldi K Sadanov und 10 weiteren Autor:innen. Beteiligte Einrichtung: LLP "Research and Production Center for Microbiology and Virology", Almaty 050010, Kazakhstan. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program-targeted funding of the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakh-stan, program-targeted funding of the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbial engineering has made a significant breakthrough in pharmaceutical biotechnology, greatly expanding the production of biologically active compounds, therapeutic proteins, and novel drug candidates. Recent advancements in genetic engineering, synthetic biology, and adaptive evolution have contributed to the optimization of microbial strains for pharmaceutical applications, playing a crucial role in enhancing their productivity and stability. The CRISPR-Cas system is widely utilized as a precise genome modification tool, enabling the enhancement of metabolite biosynthesis and the activation of synthetic biological pathways. Additionally, synthetic biology approaches allow for the targeted design of microorganisms with improved metabolic efficiency and therapeutic potential, thereby accelerating the development of new pharmaceutical products. The integration of artificial intelligence (AI) and machine learning (ML) plays a vital role in further advancing microbial engineering by predicting metabolic network interactions, optimizing bioprocesses, and accelerating the drug discovery process. However, challenges such as the efficient optimization of metabolic pathways, ensuring sustainable industrial-scale production, and meeting international regulatory requirements remain critical barriers in the field. Furthermore, to mitigate potential risks, it is essential to develop stringent biocontainment strategies and implement appropriate regulatory oversight. This review comprehensively examines recent innovations in microbial engineering, analyzing key technological advancements, regulatory challenges, and future development perspectives.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencebiopharmaceuticalsmachine learningmicrobial engineeringsynthetic biology

Autor:innen und Institutionen

  • LLP "Research and Production Center for Microbiology and Virology", Almaty 050010, Kazakhstan.
  • Department of Chemical and Biochemical Engineering, Geology and Oil-Gas Business Institute Named After K. Turyssov, Satbayev University, Almaty 050043, Kazakhstan.
  • Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
  • Ecology Research Institute, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan 161200, Kazakhstan.

ORCID-Profile: Baiken B Baimakhanova, Zere Z Turlybaeva, Gul B Baimakhanova, Anel A Omirbekova

Förderung

  • Program-targeted funding of the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakh-stan
  • program-targeted funding of the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan

Zitieren

APA

Sadanov, A. K., Baimakhanova, B. B., Orasymbet, S. E., Ratnikova, I. A., Turlybaeva, Z. Z., Baimakhanova, G. B., Amitova, A. A., Omirbekova, A. A., Aitkaliyeva, G. S., Kossalbayev, B. D., & Belkozhayev, A. M. (2025). Engineering Useful Microbial Species for Pharmaceutical Applications. Microorganisms, 13(3), 599. https://doi.org/10.3390/microorganisms13030599

Vancouver

Sadanov AK, Baimakhanova BB, Orasymbet SE, Ratnikova IA, Turlybaeva ZZ, Baimakhanova GB, et al. Engineering Useful Microbial Species for Pharmaceutical Applications. Microorganisms. 2025;13(3):599. doi:10.3390/microorganisms13030599

BibTeX
@article{Sadanov2025,
  author = {Sadanov, Amankeldi K and Baimakhanova, Baiken B and Orasymbet, Saltanat E and Ratnikova, Irina A and Turlybaeva, Zere Z and Baimakhanova, Gul B and Amitova, Aigul A and Omirbekova, Anel A and Aitkaliyeva, Gulzat S and Kossalbayev, Bekzhan D and Belkozhayev, Ayaz M},
  title = {Engineering Useful Microbial Species for Pharmaceutical Applications},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {599},
  doi = {10.3390/microorganisms13030599}
}
Kostenlos starten →